ZDHHC5 promotes GAD pathogenesis by modulating SSC‐A on CD4+ T cells, revealing novel immune‐mediated mechanisms and therapeutic targets for GAD. This evidence concerns the gene ZDHHC5 and generalized anxiety disorder.